Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.30
Delayed Data
As of 3:31pm ET
 -0.1001 / -4.17%
Today’s Change
1.93
Today|||52-Week Range
4.70
+0.56%
Year-to-Date
Institutional investors purchased a net $10.7 thousand shares of XTLB during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 3.72% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Other institutional3.06%
Mutual fund holders0.66%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

12/31/2017SABBY CAPITAL LLC  Sold 11.5 Thousand shares of X T L Biopharmaceuticals ...

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC2.59%133,332304,930-11,495-7.94%
Invesco Asset Management Ltd.0.51%25,96159,37300.00%
G1 Execution Services LLC0.23%11,55126,417+11,551--
Morgan Stanley & Co. LLC0.18%9,16020,949+2,500+37.54%
IBI Mutual Funds Management (1978...0.16%8,06018,43300.00%
UBS Securities LLC0.06%3,0406,952-13,269-81.36%

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perpetual Income & Growth Investm...0.38%19,60244,830+108+0.55%
I.B.I. Foreign Equity Liable0.16%8,06018,43300.00%
Keystone Investment Trust Plc0.10%5,16811,819+5,168--
Invesco Perpetual UK 2 Invt. Seri...0.02%1,1912,72400.00%